Inositols: From Established Knowledge to Novel Approaches
Open accessThe DOI matches its Crossref record; 200 of the 201 references it cites were found in a registry or an index.
Abstract
Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction, myo-Ins and D-chiro-Ins supplementation has contributed to clinical approaches in ameliorating many gynecological and endocrinological diseases. Currently both myo-Ins and D-chiro-Ins are well-tolerated, effective alternative candidates to the classical insulin sensitizers, and are useful treatments in preventing and treating metabolic and reproductive disorders such as polycystic ovary syndrome (PCOS), gestational diabetes mellitus (GDM), and male fertility disturbances, like sperm abnormalities. Moreover, besides metabolic activity, myo-Ins and D-chiro-Ins deeply influence steroidogenesis, regulating the pools of androgens and estrogens, likely in opposite ways. Given the complexity of inositol-related mechanisms of action, many of their beneficial effects are still under scrutiny. Therefore, continuing research aims to discover new emerging roles and mechanisms that can allow clinicians to tailor inositol therapy and to use it in other medical areas, hitherto unexplored. The present paper outlines the established evidence on inositols and updates on recent research, namely concerning D-chiro-Ins involvement into steroidogenesis. In particular, D-chiro-Ins mediates insulin-induced testosterone biosynthesis from ovarian thecal cells and directly affects synthesis of estrogens by modulating the expression of the aromatase enzyme. Ovaries, as well as other organs and tissues, are characterized by a specific ratio of myo-Ins to D-chiro-Ins, which ensures their healthy state and proper functionality. Altered inositol ratios may account for pathological conditions, causing an imbalance in sex hormones. Such situations usually occur in association with medical conditions, such as PCOS, or as a consequence of some pharmacological treatments. Based on the physiological role of inositols and the pathological implications of altered myo-Ins to D-chiro-Ins ratios, inositol therapy may be designed with two different aims: (1) restoring the inositol physiological ratio; (2) altering the ratio in a controlled way to achieve specific effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, insulin resistance (IR) has a central role in its pathogenesis [5–7].”
From Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During the secondary signaling mechanisms, inositol triphosphate (IP3) will also be released, which can be converted to free myoinositol by inositol-monophosphatase [6].”
From Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, DCI is an aromatase inhibitor and promotes glycogen synthase, which inhibits the conversion of androgens to estrogens, resulting in the accumulation of androgens and lack of estrogens.”
From Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in the short term, it can improve insulin levels, thus promoting SHBG production [6].”
From Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inositols are considered insulin sensitizers, as they modulate the members of insulin signaling pathways [6].”
From Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
- Retracted
Marín, I. H., Picconi, O., Laganà, A. S., Costabile, L., & Unfer, V. (2021) · PubMed · doi:10.26355/eurrev_202104_25743 · Cited by 31
Self-citationRetracted(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
(1991) · The Lancet · doi:10.1016/0140-6736(91)90133-a · Cited by 3,472
Phosphoinositides in cell regulation and membrane dynamics
Di Paolo, G., & De Camilli, P. (2006) · Nature · doi:10.1038/nature05185 · Cited by 2,790
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954 · cited 1×
“Within the male population a potential target for D-chiro-Ins administration might be elderly men suffering from late-onset hypogonadism (LOH), who present with an impaired production of adequate levels of testosterone by testis and sperm cells, resulting in androgen deficiency [142,143].”
BackgroundSneddon, J., Densem, J. W., Wald, N. J., Frost, C., Stone, R., & Gnant, M. (1991) · PubMed · Cited by 1,812
The causes of reduced fertility with cryopreserved semen
Watson, P. F. (2000) · Animal Reproduction Science · doi:10.1016/s0378-4320(00)00099-3 · Cited by 1,553
Sambuy, Y., De Angelis, I., Ranaldi, G., Scarino, M. L., Stammati, A., & Zucco, F. (2005) · Cell Biology and Toxicology · doi:10.1007/s10565-005-0085-6 · Cited by 1,488 · cited 1×
“discovered that, in presence of α-LA, myo-Ins increased its passage across the Caco-2 cell monolayer, used as a standard in vitro model of intestinal epithelium [182].”
Background
Research works printed but not linked: 2
- Maquenne, 1887, Préparation, proprietés et constitution se l’inosite, CR Hebd. Séance Acad. Sci. Paris, 104, 225
- 2021, D-Chiro-Inositol, vitamin D and epigallocatechin gallate avoid surgery in women with uterine fibroids: 2 case reports, Eur. Med. J., 9, 95
Cited by
Zhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01091-0 · Cited by 408
“proportion of DCI improves the health of organs and tissues, while long-term high-dose DCI monotherapy in women with PCOS has a negative impact [184].”
BackgroundArmanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
“On the contrary, the supplementation of DCI alone may worsen the insulin-mediated androgen synthesis and fertility in PCOS women [53].”
BackgroundResultGreff, D., Juhász, A. E., Váncsa, S., Váradi, A., Sipos, Z., Szinte, J., Park, S., Hegyi, P., Nyirády, P., Ács, N., et al. (2023) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01055-z · Cited by 143
“During the secondary signaling mechanisms, inositol triphosphate (IP3) will also be released, which can be converted to free myoinositol by inositol-monophosphatase [6].”
BackgroundInfluentialFitz, V., Graca, S., Mahalingaiah, S., Liu, J., Lai, L., Butt, A., Armour, M., Rao, V., Naidoo, D., Maunder, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad762 · Cited by 70
“Mechanistically, MI promotes translocation of the glucose transporter type 4 to the plasma membrane for glucose uptake (7) and also reduces release of free fatty acids from adipose tissue (8).”
BackgroundEffect of gestational diabetes mellitus on lipid profile: A systematic review and meta-analysis
Rahnemaei, F. A., Pakzad, R., Amirian, A., Pakzad, I., & Abdi, F. (2021) · Open Medicine · doi:10.1515/med-2021-0408 · Cited by 83
“They are effective alternatives to classical insulin sensitizers and are useful in the prevention and treatment of metabolic and reproductive disorders such as polycystic ovary syndrome and GDM [2,3].”
BackgroundQuestioning PCOS phenotypes for reclassification and tailored therapy
Myers, S. H., Russo, M., Dinicola, S., Forte, G., & Unfer, V. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.08.005 · Cited by 74
Self-citationIsaković, J., Šimunić, I., Jagečić, D., Hribljan, V., & Mitrečić, D. (2022) · Biomedicines · doi:10.3390/biomedicines10050965 · Cited by 75
“Therefore, additional research into the potential mechanisms and roles of inositol during neural tube development, including its potential therapeutic use, is necessary [105].”
BackgroundUnfer, V., Kandaraki, E., Pkhaladze, L., Roseff, S., Vazquez-Levin, M. H., Laganà, A. S., Chan, S. Y., Yap‐Garcia, M. I. M., Greene, N. D. E., Soulage, C. O., et al. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100159 · Cited by 69
“Hence, even if several authors endorsed inositol administration as beneficial treatment for patients with PCOS (Dinicola et al., 2021), new evidence based on the above-mentioned differences in response rates suggest that it might not be effective in all PCOS patients.”
Self-citationBarrea, L., Vetrani, C., Verde, L., Frías-Toral, E., Ceriani, F., Cernea, S., Docimo, A., Graziadio, C., Tripathy, D., Savastano, S., et al. (2023) · Antioxidants · doi:10.3390/antiox12040904 · Cited by 61
Pililis, S., Lampsas, S., Kountouri, A., Pliouta, L., Korakas, E., Livadas, S., Thymis, J., Peppa, Μ., Kalantaridou, S., Oikonomou, E. K., et al. (2024) · Medicina · doi:10.3390/medicina60101656 · Cited by 63
“Inositols are regarded as insulin sensitizers because they regulate components of insulin signaling pathways [146].”
BackgroundMyo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review
Bizzarri, M., Monti, N., Piombarolo, A., Angeloni, A., & Verna, R. (2023) · Nutrients · doi:10.3390/nu15081875 · Cited by 55
“The discovery of its influence on endocrine signal transduction has contributed to ameliorating treatments of numerous endocrinological and gynecological syndromes [12].”
BackgroundSelf-citationSun, P., Zhang, Y., Sun, L.-L., Sun, N., Wang, J., & Ma, H.-G. (2023) · BMC Women s Health · doi:10.1186/s12905-022-02154-6 · Cited by 44
“Currently, myo-inositol is considered effective in treating infertility and menstrual irregularities in patients with PCOS [44, 47].”
BackgroundMyo-inositol in assisted reproductive technology from bench to bedside
Etrusco, A., Laganà, A. S., Chiàntera, V., Buzzaccarini, G., & Unfer, V. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.09.005 · Cited by 48
Self-citationNovel Chemical and Biological Insights of Inositol Derivatives in Mediterranean Plants
Siracusa, L., Napoli, E., & Ruberto, G. (2022) · Molecules · doi:10.3390/molecules27051525 · Cited by 42
“Thanking tissue-specific epimerase enzymes, myo-ins can be converted into its stereoisomer D-chiro-inositol under adequate molecular stimulation (insulin), in order to obtain the proper balance between the two [60,63].”
BackgroundShi, L., Yu, X., Li, H., Wu, G.-S., & Luo, H. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112145 · Cited by 36
Benvenga, S., Famà, F., Perdichizzi, L. G., Antonelli, A., Brenta, G., Vermiglio, F., & Moleti, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.891233 · Cited by 36
Self-citationWei, J., Yan, J., & Yang, H. (2022) · Nutrients · doi:10.3390/nu14142831 · Cited by 36
“By increasing glucose transporter type 4 (GLUT4) translocation to the cell membrane, MI and DCI act as insulin sensitizers, thereby decreasing insulin resistance and plasma glucose levels [7,8].”
BackgroundMoslehi, N., Zeraattalab-Motlagh, S., Rahimi Sakak, F., Shab-Bidar, S., Tehrani, F. R., & Mirmiran, P. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuac075 · Cited by 28
Tharayil, S. P., & Shukla, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136233 · Cited by 33
“However, DCI supplementation could exacerbate insulin-mediated androgen production and fertility in women with PCOS [176,186].”
Nazirudeen, R., Sridhar, S., Priyanka, R., Sumathi, B., Natarajan, V., Eagappan, S., Raghavan, K. S., & Jayaraman, S. (2023) · Clinical Endocrinology · doi:10.1111/cen.14931 · Cited by 33
“There are very limited studies globally comparing MI and metformin‐based therapies with equivocal results.7–10 In addition there are no clear consensuses and guidelines regarding the use of MI in PCOS, however in off‐label, MI‐based therapies are being increasingly used in clinical practice in women with PCOS.1 The dr…”
BackgroundInfluentialZhang, X., Ma, Q., Jia, L., He, H., Zhang, T., Jia, W., Zhu, L., Qi, W., & Wang, N. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126860 · Cited by 29
Tiptiri-Kourpeti, A., Asimakopoulos, B., & Nikolettos, N. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041066 · Cited by 26
“There are more substances used specifically to select better spermatozoa, e.g., Myoinositol [101,102] for OAT samples and ATP/MgSO 4 for immotile spermatozoa, but these have been characterized better as activating agents than selection techniques [97].”
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Li, J.-M., Chang, W., Li, L., Yang, D. C. H., Hsu, S., Kenyon, N. J., & Chen, C. (2023) · Respiratory Research · doi:10.1186/s12931-023-02421-6 · Cited by 23
“Myo-inositol (or inositol) is a natural compound provided by dietary uptake and/or endogenously synthesized through the glycolysis pathway [19].”
BackgroundIzquierdo, D., Roura, M., Pérez‐Trujillo, M., Soto‐Heras, S., & Paramio, M. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084141 · Cited by 18
“Myo-inositol, the steroisomer of inositol most diffused in nature, is an organic osmolyte that regulates cellular responses to hypertonic environments and it is incorporated into cell membranes as phosphatidyl-myoinositol, the precursor of inositol triphosphate (InsP3), which acts as second messenger in the transducti…”
BackgroundPutative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients
Petrillo, T., Semprini, E., Tomatis, V., Arnesano, M., Ambrosetti, F., Battipaglia, C., Sponzilli, A., Ricciardiello, F., Genazzani, A. R., & Genazzani, A. D. (2022) · Biomedicines · doi:10.3390/biomedicines10081924 · Cited by 23
“The increase of MYO improves FSH sensitivity, restoring the ovulation rate [77].”
BackgroundKamenov, Z. A., Gateva, A., Dinicola, S., & Unfer, V. (2023) · Metabolites · doi:10.3390/metabo13060717 · Cited by 19
Self-citationGreff, D., Váncsa, S., Váradi, A., Szinte, J., Park, S., Hegyi, P., Nyírády, P., Ács, N., Horvath, E. M., & Várbíró, S. (2023) · Nutrients · doi:10.3390/nu15194224 · Cited by 18
“This reaction allows every tissue to develop a proper balance between DCI and myoinositol, ensuring normal metabolic functions [19].”
BackgroundLete, I., Martínez, A., Lasaga, I., Centurión, E., & Vesga, A. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2301554 · Cited by 28
“Altered inositol ratios may account for pathological conditions, causing an imbalance in sex hormones [18].”
Fedeli, V., Unfer, V., Dinicola, S., Laganà, A. S., Canipari, R., Monti, N., Querqui, A., Galante, E., Laurenzi, G., & Bizzarri, M. (2024) · Cells · doi:10.3390/cells13141171 · Cited by 19
Self-citationGeraci, G., Riccio, C., Oliva, F. G., Gabrielli, D., Colivicchi, F., Grimaldi, M., Facchinetti, F., & Unfer, V. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1520490 · Cited by 24
Self-citationPositive Effects of α-Lactalbumin in the Management of Symptoms of Polycystic Ovary Syndrome
Cardinale, V., Lepore, E., Basciani, S., Artale, S. A., Nordio, M., Bizzarri, M., & Unfer, V. (2022) · Nutrients · doi:10.3390/nu14153220 · Cited by 19
“To date, the use of α-LA in this syndrome is just considered in association with inositols [61,62], aiming to improve their intestinal adsorption and overcoming the common problem of inositol resistance occurring in some of these patients [63–65].”
BackgroundSelf-citationLong-Lasting Therapies with High Doses of D-chiro-inositol: The Downside
Nordio, M., Espinola, M. S. B., Bilotta, G., Capoccia, E., & Oliva, M. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12010390 · Cited by 17
“Recent literature reports have suggested possible detrimental effects for long treatments with high dosages of DCI, due to its molecular activities [3,6,7].”
BackgroundSelf-citationMonastra, G., Gambioli, R., Unfer, V., Forte, G., Maymó‐Masip, E., & Comitato, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087421 · Cited by 18
“As therapeutic agents, both stereoisomers exert an insulin-mimetic activity and are also effective against insulin resistance [10,11].”
BackgroundSelf-citationQi, H., Deng, F., Wang, Y., Zhang, H., Kanwar, Y. S., & Dai, Y. (2022) · Cells · doi:10.3390/cells12010016 · Cited by 18
“The myo-inositol is a carbocyclic sugar that is involved in various biological processes, such as acting as a second messenger in diverse signaling events in mammalian systems [28].”
BackgroundNutraceuticals and polycystic ovary syndrome: a systematic review of the literature
Menichini, D., Ughetti, C., Monari, F., Vinci, P. L. D., Neri, I., & Facchinetti, F. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2089106 · Cited by 20
Self-citationMukherjee, P., Sanyal, S., Chadha, S., & Mukherjee, S. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303266512231103075551 · Cited by 19
Metabolomic profiling identifies novel metabolites associated with cardiac dysfunction
Culler, K. L., Sinha, A., Filipp, M. E., Giro, P., Allen, N. B., Taylor, K. D., Guo, X., Thorp, E. B., Freed, B. H., Greenland, P., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71329-y · Cited by 14
“It is possible that myo-inositol levels could be upregulated in response to disorders in glucose control which also contribute to future development of HF, as myo-inositol and its downstream metabolites are important in glucose uptake and glycogen storage, as well as insulin sensitization 35 .”
BackgroundPayer, J., Jackuliak, P., Kužma, M., Džupon, M., & Vaňuga, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1067029 · Cited by 15
“were women of reproductive age (18-50), who exhibit values of TSH in the”
BackgroundTreatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes
Unfer, V., Russo, M., Aragona, C., Bilotta, G., Oliva, M. M., & Bizzarri, M. (2023) · Biomedicines · doi:10.3390/biomedicines11061759 · Cited by 18
“The fundamental role of myo-Ins in PCOS has been endorsed worldwide for more than 20 years [26], but this is the first retrospective study comparing the effects of myo-Ins treatment in different PCOS phenotypes.”
BackgroundSelf-citationSLC5A3 is important for cervical cancer cell growth
Li, L., Shen, F., Cheng, Q., Sun, J. P., Li, H., Sun, H.-T., Cai, X., Chen, M., Yang, B., Wang, L., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.84570 · Cited by 12
“MI is used to treat reproductive and metabolic disorders [38].”
MethodBéresniak, A., Russo, M., Forte, G., Laganà, A. S., Oliva, M. M., Aragona, C., Chiàntera, V., & Unfer, V. (2023) · Scientific Reports · doi:10.1038/s41598-023-44055-0 · Cited by 12
“These data strengthen the evidence regarding the potential beneficial role of myo-Ins during ART treatments to sustain fertilization and pregnancy achievement, starting from the phase of ovarian stimulation 30,40 .”
BackgroundSelf-citationPhosphoinositide Metabolism: Biochemistry, Physiology and Genetic Disorders
Rossignol, F., Lamari, F., & Mitchell, G. A. (2025) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.70008 · Cited by 16
“Dephosphorylation produces free inositol [7].”
InfluentialBasciani, S., Nordio, M., Dinicola, S., Unfer, V., & Gnessi, L. (2023) · Nutrients · doi:10.3390/nu15143142 · Cited by 14
“The clinical study by Montanino and colleagues indicated that adding 50 mg of α-LA to 2 g of myo-Ins twice a day, restored ovulation in 86% of inositol-resistant women with PCOS.”
BackgroundInfluentialSelf-citationTinelli, A., Panese, G., Licchelli, M., Morciano, A., Pecorella, G., & Gambioli, R. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07324-x · Cited by 11
Oocyte and dietary supplements: a mini review
Chen, H., Wang, S., Song, M., Yang, D., & Li, H. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1619758 · Cited by 15
Laganà, A. S., Myers, S. H., Forte, G., Naem, A., Krentel, H., Allahqoli, L., Alkatout, İ., & Unfer, V. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2306851 · Cited by 14
“It could be hypothesized that this range considered physiological ratios typically seen in blood and within various tissues in the body, which can range from 65:35 in fat tissue to 99.5:0.5 in theca cells, with MI typically in greater amounts than DCI [40].”
BackgroundInfluentialSelf-citationNani, A., Bertuzzi, F., Meneghini, E., Mion, E., & Pintaudi, B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247650 · Cited by 10
“Inositols, particularly myo-inositol (myo-Ins) and D -chiro-inositol ( D -chiro-Ins), are natural molecules that positively modulate both glucose and lipid profiles through well-understood metabolic pathways [13].”
BackgroundInfluentialInvestigating Genetic Determinants of Plasma Inositol Status in Adult Humans
Weston, E., Pangilinan, F., Eaton, S. D., Orford, M., Leung, K., Copp, A. J., Mills, J. L., Molloy, A. M., Brody, L. C., & Greene, N. D. E. (2022) · Journal of Nutrition · doi:10.1093/jn/nxac204 · Cited by 10
“Although MI signaling, via the IP3 receptor, is involved in oocyte maturation, and inositol status is thought to modulate fertility in females and males (12, 61), it is not clear how a ZP2-associated variant could affect circulating MI.”
BackgroundSelf-citationClinical implications of the 100-g oral glucose tolerance test in the third trimester
Shqara, R. A., Or, S., Wiener, Y., Lowenstein, L., & Wolf, M. F. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06520-5 · Cited by 12
Biological Properties of Cyclitols and Their Derivatives
Kuş, N. Ş. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202301064 · Cited by 9
Wdowiak, A., Bakalczuk, S., Filip, M., Laganà, A. S., & Unfer, V. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020558 · Cited by 9
Self-citationPolycystic ovary syndrome: An update on diagnosis and management
Sung, N., Amir, J., Alwahab, U. A., & Falcone, T. (2026) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.93a.25090 · Cited by 10
“32 Metformin has been used off-label for PCOS for a long time.”
Dinicola, S., Unfer, V., Soulage, C. O., Yap‐Garcia, M. I. M., Bevilacqua, A., Benvenga, S., Barbaro, D., Wdowiak, A., Nordio, M., Dewailly, D., et al. (2024) · Gynecologic and Obstetric Investigation · doi:10.1159/000536081 · Cited by 11
“Myo-Ins controls D -chiro-Ins levels within the cell, due to the aforementioned conversion process; therefore, the synthesis of myo-Ins is important to consider when contemplating the effect of D -chiro-Ins within the body [10].”
InfluentialSelf-citationGul, M., Khan, H., Rauf, B., Bukhari, S. M. S., Ehtesham, E., Malik, M. O., Shah, F. A., Alanazi, F. E., & Shah, M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03813-9 · Cited by 10
“D-chiro-inositol (DCI) is a stereoisomer of inositol that complements MI by increasing insulin receptor sensitivity and maintaining euglycemia (Dinicola et al. 2021).”
Contreras, A., Jones, M. K., Eldon, E. D., & Klig, L. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044185 · Cited by 9
Blasi, I., Daolio, J., Pugni, V., Comitini, G., Morciano, M., Grassi, G., Todros, T., Gargano, G., & Aguzzoli, L. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282895 · Cited by 8
“Of note, we found of interest the role of myo-inositol and D-chiro-inositol for the prevention and treatment of metabolic disorders, such as GDM [37,38], but we await future studies to fully examine the beneficial effects.”
RetractedChen, S., Zhou, Z., Zhou, Z., Liu, Y., Sun, S., Huang, K., Yang, Q., & Guo, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1307944 · Cited by 9
“With high levels negatively affecting the quality of oocytes and blastocysts (45), D-chiro-inositol performs an instrumental role in the maintenance of normal ovarian function and state of health, making strict regulation of its abundance a necessity (46).”
BackgroundMoretti, C., Bonomi, M., Dionese, P., Federici, S., Fulghesu, A. M., Giannelli, J., Giordano, R., Guccione, L., Maseroli, E., Moghetti, P., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02363-w · Cited by 10
“Inosi-tols regulate different physiological processes, such as ion channel permeability, cytoskeleton remodeling, vascular response, and endocrine signal transduction, and have anti-inflammatory/antioxidant effects [5, 6].”
Leo, V. D., Tosti, C., Morgante, G., Ponchia, R., Luddi, A., Governini, L., & Piomboni, P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071991 · Cited by 10
“In particular, inositol seems to have specific effects on certain hormonal markers, favouring an increase in plasma concentrations of LH, followed by those of testosterone, through stimulation of Leydig cells in the testicles interstitium [14].”
BackgroundOvchinnikov, R. I. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-5-46-53 · Cited by 8
Preda, A., Stefan, A. G., Vladu, I. M., Fortofoiu, M.-C., Clenciu, D., Fortofoiu, M., Gheorghe, I. O., Comanescu, A. C., & Mota, M. (2022) · Journal of Diabetes Research · doi:10.1155/2022/2367213 · Cited by 8
Application of Multigene Panels Testing for Hereditary Cancer Syndromes
Bilyalov, A. I., Nikolaev, S., Shigapova, L. H., Хатьков, И. Е., Михайловна, Д. А., Zhukova, L., Смолин, С., Titova, M., Lisica, T., Бодунова, Н. А., et al. (2022) · Biology · doi:10.3390/biology11101461 · Cited by 8
Physiological and pathophysiological roles of inositols
Monastra, G., Dinicola, S., & Unfer, V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91673-8.00008-x · Cited by 7
Self-citationDellino, M., Cascardi, E., Leoni, C., Fortunato, F., Fusco, A., Tinelli, R., Cazzato, G., Scacco, S., Gnoni, A., Scilimati, A., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091536 · Cited by 7
“Specifically, in women, MI represents an FSH second messenger and orchestrates FSH-mediated pathways that control the proliferation and maturation of granulosa cells [21].”
BackgroundSelf-citationFontana, A., Falasconi, I., Bellassi, P., Fanfoni, E., Puglisi, E., & Morelli, L. (2023) · Microorganisms · doi:10.3390/microorganisms11030587 · Cited by 7
“Thus, its important role in hyperinsulinemia reduction and ovarian function restoration has been suggested [68,69].”
BackgroundD-Chiro-inositol and PCOS: between myth and reality. The never-ending story
Cianci, A., & Vitale, S. G. (2022) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2022.2029830 · Cited by 7
The role of berberine in polycystic ovary syndrome — a summary of knowledge
Jurgiel, J., Graniak, A., Opyd, P., Zawodny, T., & Lis, M. (2023) · Ginekologia Polska · doi:10.5603/gpl.95138 · Cited by 12
“Inositol also acts as a second messenger of FSH signalling in the ovary, restoring regular menses [47, 48].”
BackgroundMyo-inositol rescued insulin resistance and dyslipidemia in db/db mice
Long, L., Huang, Q., Song, T., & Dai, Z. (2024) · Journal of Applied Biomedicine · doi:10.32725/jab.2024.009 · Cited by 6
“…(PI), MI polyphosphates (IPs), and phosphoinositides (PIPs), have a significant impact on several indispensable processes of cell physiology involving cell adhesion, cell signaling, and vesicular trafficking (Baldassarre et al., 2021; Dinicola et al., 2021; Gajewiak et al., 2006).”
The Potential Application of Clitoria ternatea for Cancer Treatment
Purnamayanti, A., Budipramana, K., & Gondokesumo, M. E. (2022) · Pharmaceutical Sciences and Research · doi:10.7454/psr.v9i3.1253 · Cited by 12
Zaki, A. K. A., Alharbi, N. S., Almundarij, T. I., & Albarrak, S. M. (2025) · Veterinární Medicína · doi:10.17221/116/2024-vetmed · Cited by 5
“Inositols are considered insulin sensitisers because they alter the components of the insulin signalling pathways (Dinicola et al. 2021).”
A bitter pill to swallow: adjustments to oral contraceptive pill use in polycystic ovary syndrome
Calcagno, M., Serra, P., Etrusco, A., Margioula‐Siarkou, C., Terzic, S., Giannini, A., Garzon, S., Ferrari, F. G., Dellino, M., & Laganà, A. S. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2371977 · Cited by 8
“Inositol is a second messenger of several hormones, including follicle-stimulating hormone (FSH), thyroid stimulating hormone (TSH) and insulin, and it is used in PCOS therapy as an insulin sensitizer which restores androgen levels back to a tolerable range [59].”
Self-citationCipriani, F., Gnessi, L., Watanabe, M., & Baldelli, R. (2025) · Nutrients · doi:10.3390/nu17121999 · Cited by 5
“It is therefore difficult to consume sufficient amounts of DCI, which is indeed mainly synthesized in the body from MI [26].”
Ibrahim, Z. A. H., Abdulridha, M. K., & Razoqi, R. B. (2023) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v23i3.1045 · Cited by 5
Myo-inositol in the treatment of male factor infertility
Ших, Е. В., Grebenshikova, L. Y., Zhukova, О. V., & Bagdasaryan, A. A. (2022) · GYNECOLOGY · doi:10.26442/20795696.2022.4.201822 · Cited by 6
“Влияние инозитолов на подвижность сперматозоидов может быть обусловлено несколькими эффектами, в том числе сенсибилизирующими к инсулину свойствами, антиоксидантной и прокинетической активностью, а также гормональными регуляторными эффектами [16, 17].”
Impact of subclinically hypocalcemic stress on the plasma metabolomic profile of dairy goats
Zhang, J., Yang, D., Zeng, Y., Guo, K., Zhang, J., Huang, Y., Sui, Y., Liu, Q., Mo, X., Zhao, C., et al. (2025) · Animal Bioscience · doi:10.5713/ab.24.0567 · Cited by 4
“Due to the concentration of Ca ions related to smooth muscle contraction, vascular smooth muscle tension can be regulated by a series of agonists that act through receptor-mediated trans-membrane signaling pathways to alter the concentration of key intracellular second messengers [26].”
Critical appraisal on neural tube defects and their complexities
Shaikh, F., Sanadhya, M., Kaleem, S., Verma, T., Jayaraj, R. L., & Ahmad, F. (2025) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2024.07.015 · Cited by 7
D-Chiro-Inositol in Endometrial Hyperplasia: A Pilot Study
Porcaro, G., Bilotta, G., Capoccia, E., Espinola, M. S. B., & Aragona, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210080 · Cited by 5
“Over the years, DCI has been used in the clinical practice of several clinical pictures, including insulin resistance and PCOS [19,21,31].”
BackgroundSelf-citationAragona, C., Russo, M., Myers, S. H., Espinola, M. S. B., Bilotta, G., & Unfer, V. (2025) · Health Economics Review · doi:10.1186/s13561-025-00609-8 · Cited by 5
“In addition to playing a key role in glucose metabolism, myo-Ins has crucial functions in the physiology of human reproduction [9, 10], with elevated myo-Ins levels in human follicular fluid correlating positively with satisfactory oocyte quality [11].”
Self-citationSánchez, A. A., Castillo, N., García-Vidal, E., Chadid, M. L., Ballada, C. S., Ricart, G. V., & Pellens, V. T. (2024) · Clinical Medicine Insights Case Reports · doi:10.1177/11795476241242265 · Cited by 4
Pivazyan, L. G., Krylova, E., Obosyan, L. B., Seregina, V., Shapovalenko, R., & Ayryan, E. (2024) · Gynecologic and Obstetric Investigation · doi:10.1159/000540023 · Cited by 8
“Indeed, as demonstrated by a considerable decrease in the number of gonadotropin units needed, myo-inositol treatment in these patients greatly enhanced ART outcomes, including fertilization rate, gonadotropin, and ovarian sensitivity index [65].”
Oral supplementation of inositols effectively recovered lithium-induced cardiac dysfunctions in mice
L’Abbate, S., Nicolini, G., Forini, F., Lepore, E., Marchetti, S., Unfer, V., Forte, G., & Kusmic, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117287 · Cited by 3
Self-citationThe Role of Inositols in Endocrine and Neuroendocrine Tumors
Mormando, M., Puliani, G., Bianchini, M., Lauretta, R., & Appetecchia, M. (2024) · Biomolecules · doi:10.3390/biom14081004 · Cited by 3
“…it can be found as phosphatidyl-myoinositol, the precursor of inositol triphosphate (IP3), which acts as a second messenger in the transduction of several endocrine signals, including FSH, TSH and insulin [26]. in the transduction of several endocrine signals, including FSH, TSH and insulin [26].”
BackgroundSelf-citationMazzera, I., Graziano, A., Vizzielli, G., & Driul, L. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2411727 · Cited by 3
Metformin and Myo-Inositol: A Comparative Analysis
Russo, M., Oliva, M. M., Nordio, M., Porcaro, G., & Unfer, V. (2025) · Gynecologic and Obstetric Investigation · doi:10.1159/000549646 · Cited by 5
“Myo-inositol is an endogenous mediator that plays an important role in numerous biological processes including insulin signaling in addition to acting as a second messenger for follicle-stimulating hormone (FSH), thus modulating steroidogenesis [22].”
InfluentialSelf-citationSpritzer, P. M., dos Santos, G. R., Vega, M. L. M., Chedraui, P. A., Pilnik, S., Lascano, A. C., Belardo, A., Elizalde-Cremonte, A., Ramírez, A. V., Balán, A. R., et al. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2456578 · Cited by 4
“In women with PCOS, hyperinsulinemia may increase ovarian epimerase activity, potentially disrupting the balance between MI and DCI by favoring excessive DCI synthesis, which could compromise MI-dependent processes such as aromatase activity in granulosa cells and contribute to androgen excess [19].”
Du, W., Jing, X., Wang, Z. Y., Hou, X., & Tang, S.-F. (2026) · Chemistry of Materials · doi:10.1021/acs.chemmater.6c00537 · Cited by 2
Irfan, N. U. A., Saleem, S., & Irfan, A. (2026) · Clinical Endocrinology · doi:10.1111/cen.70188 · Cited by 2
Atualidades no Diabetes gestacional
Machado, L. F., & Vasconcellos, M. J. D. A. (2022) · Brazilian Journal of Health Review · doi:10.34119/bjhrv5n6-029 · Cited by 2
Gestational Diabetes and Infertility
Turan, G. A., & Delibaşı, T. (2023) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2023.132016 · Cited by 2
Arefhosseini, S., Ebrahimi‐Mameghani, M., Asghari, S., Barzegari, A., & Roshanravan, N. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106197 · Cited by 3
Pkhaladze, L., Kamenov, Z. A., Nordio, M., Myers, S. H., & Unfer, V. (2024) · Gynecologic and Obstetric Investigation · doi:10.1159/000541287 · Cited by 2
“Currently, inositol is utilized as an insulin sensitizer in a similar manner to metformin in the fi eld of polycystic ovary syndrome (PCOS) and is also known to be involved in steroidogenesis [1].”
Self-citationSobhanifar, A., Arefhosseini, S., Tutunchi, H., Arefhosseini, S. R., & Ebrahimi‐Mameghani, M. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106056 · Cited by 3
Tempeh-type fermentation: impact on food composition, bioaccessibility, and health benefits
Velásquez-Jiménez, D., Kassandra, D.-F. S., Nicolle, M.-Z. E., & Campos-Vega, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21874-3.00002-7 · Cited by 2
Unfer, V., Dinicola, S., Sara, R., & Sandro, G. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110860 · Cited by 3
Self-citationGuo, J., Chen, Z., Yue, H., Li, S., Sun, G., Zhang, F., Zhong, R., Lyu, J., Yang, Y., Wang, X., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04972-9 · Cited by 3
“Since fresh vegetables and fruits, such as beans, citrus fruits, and leafy greens, were rich dietary sources of myo-inositol [9], based on our previous dietary study [50], we speculate that low maternal consumption of fresh vegetables and fruit might lead to the reduced MI level, which increased…”
Oliva, M. M., Nordio, M., Picconi, O., & Porcaro, G. (2025) · Multidisciplinary Respiratory Medicine · doi:10.5826/mrm.2025.1051 · Cited by 1
Self-citationBelchin, P., Calvente, V., Roso, M. J. G., Exposito, E. M. G., Bueno, A. S., Fluge, M. A., & Pérez, D. O. (2026) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2026.2681759 · Cited by 2
Polycystic ovary syndrome: pragmatic management across levels of care
Arshad, A., Armeni, E., Broughton, S., Ali, A., Blendis, E., Gleeson, H. K., Robinson, L. L. L., & Kempegowda, P. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2574874 · Cited by 2
“As natural compounds, they are well-tolerated; however, their clinical benefits are still debated, partly due to the complexity of their mechanisms of action [58].”
Germinated Brown Rice: A Natural Source of Bioactive Compounds Boosting Human Health
Bosco, G., Taverniti, V., Pino, A., Caggia, C., Stadnicka, K., & Randazzo, C. L. (2026) · International Journal of Food Science · doi:10.1155/ijfo/8231866 · Cited by 1
“…myo -inositol has been reported to exert several beneficial effects on humans, such as the modulation of serotonin pathways, reducing symptoms of depression and panic disorder [85–87], and its supplementation can be used in subfertile women with and without polycystic ovary syndrome (PCOS) [88].”
Treating PCOS with inositols: Choosing the most appropriate myo- to d-chiro-inositol ratio
Bevilacqua, A., Dinicola, S., & Bizzarri, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91673-8.00006-6 · Cited by 1
Self-citation
Metadata
- Authors
- Dinicola, S., Unfer, V., Facchinetti, F., Soulage, C. O., Greene, N. D., Bizzarri, M., Laganà, A. S., Chan, S.-Y., Bevilacqua, A., Pkhaladze, L., Benvenga, S., Stringaro, A., Barbaro, D., Appetecchia, M., Aragona, C., Bezerra Espinola, M. S., Cantelmi, T., Cavalli, P., Chiu, T. T., Copp, A. J., D’Anna, R., Dewailly, D., Di Lorenzo, C., Diamanti-Kandarakis, E., Hernández Marín, I., Hod, M., Kamenov, Z., Kandaraki, E., Monastra, G., Montanino Oliva, M., Nestler, J. E., Nordio, M., Ozay, A. C., Papalou, O., Porcaro, G., Prapas, N., Roseff, S., Vazquez-Levin, M., Vucenik, I., & Wdowiak, A.
- Affiliations
- Systems Biology Group Lab, 00161 Rome, Italy
- University of Modena and Reggio Emilia (IT)
- Lyon 1 Université (FR)
- University College London (GB)
- Sapienza University of Rome (IT)
- University of Insubria (IT)
- National University of Singapore (SG)
- Zhordania and Khomasuridze Institute of Reproductology, Tbilisi 0112, Georgia
- University of Messina (IT)
- Istituto Superiore di Sanità (IT)
- Ospedale di Livorno (IT)
- Instituto Nazionale Tumori Regina Elena (IT)
- Institute for Interpersonal Cognitive Therapy, 00100 Rome, Italy
- IRCCS Humanitas Research Hospital (IT)
- IVF Centre, Hong Kong 999077, China
- Université de Lille (FR)
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome Polo Pontino, 04100 Latina, Italy
- Department of Endocrinology and Diabetes, HYGEIA Hospital, Marousi, 15123 Athens, Greece
- Human Reproduction Department, Hospital Juárez de México, Universidad Nacional Autónoma de México (UNAM), Mexico City 07760, Mexico
- Tel Aviv University (IL)
- Medical University of Sofia (BG)
- Hygeia Hospital (GR)
- Department of Obstetrics and Gynecology, Santo Spirito Hospital, 00193 Rome, Italy
- Virginia Commonwealth University (US)
- A.S.L. RMF, 00053 Civitavecchia, Italy
- Department of Obstetrics and Gynecology, Near East University Hospital, Nicosia 99138, Cyprus
- Azienda Unità Sanitaria Locale Umbria n. 2 (IT)
- Iakentro (GR)
- Reproductive Endocrinology and Infertility, South Florida Institute for Reproductive Medicine (IVFMD), Boca Raton, FL 33458, USA
- Instituto de Biología y Medicina Experimental (IBYME, CONICET-FIBYME), Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina (CONICET), Buenos Aires 2490, Argentina
- Department of Medical & Research Technology and Pathology, School of Medicine, University of Maryland, Baltimore, MD 21201, USA
- Medical University of Lublin (PL)
- Corresponding author
- Facchinetti, Fabio
- ORCID
- Dinicola, Simona
- Unfer, Vittorio
- Facchinetti, Fabio
- Soulage, Christophe O.
- Greene, Nicholas D.
- Bizzarri, Mariano
- Laganà, Antonio Simone
- Chan, Shiao-Yng
- Bevilacqua, Arturo
- Pkhaladze, Lali
- Benvenga, Salvatore
- Stringaro, Annarita
- Barbaro, Daniele
- Appetecchia, Marialuisa
- Cavalli, Pietro
- Copp, Andrew J.
- D’Anna, Rosario
- Dewailly, Didier
- Di Lorenzo, Cherubino
- Diamanti-Kandarakis, Evanthia
- Kamenov, Zdravko
- Kandaraki, Eleni
- Monastra, Giovanni
- Nordio, Maurizio
- Ozay, Ali C.
- Papalou, Olga
- Roseff, Scott
- Wdowiak, Artur
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-09-30
- Volume
- 22
- Issue
- 19
- Pages
- 10575
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8508595
- OpenAlex
- W3203286644
- Cited by
- 154
- References
- 201
- Citations by year
- 2026: 24 · 2025: 30 · 2024: 29 · 2023: 43 · 2022: 27 · 2021: 1
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
- National University of Singapore (submittedVersion, cc-by)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- LillOA (Université de Lille (University Of Lille)) (submittedVersion)
- Funders
- Action Medical Research
- Sparks (17ICH03)
- Medical Research Council (MR/T003847/1)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- myo-inositol, D-chiro-inositol, steroidogenesis, aromatase, testosterone production, polycystic ovary syndrome, gestational diabetes mellitus, male fertility, sperm abnormalities, insulin sensitizers, inositol supplementation
- MeSH terms
- Female, Humans, Inositol, Polycystic Ovary Syndrome, Pregnancy, Testosterone, Theca Cells, Molecular Structure, Signal Transduction, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.